Word

QUINCE

Status

Pending

Status Code

730

Status Date

Wednesday, January 17, 2024

Serial Number

97385224

Mark Type

4000

Filing Date

Wednesday, April 27, 2022

Published for Opposition

Tuesday, June 13, 2023

Trademark Owner History

QUINCE THERAPEUTICS, INC. - Owner At Publication
Cortexyme, Inc. - Original Applicant

Classifications

5 Pharmaceutical, medicinal and biological preparations for the treatment and prevention of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious disease, genetic disease, autoimmune disease, inflammatory disease, diabetes, cardiovascular disease, cancer, periodontal disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders

42 Medical and scientific research; pharmaceutical research and development; pharmaceutical and biological research; pharmaceutical testing; pharmaceutical product development consultation; scientific research in the nature of conducting clinical trials for others in the fields of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious disease, genetic disease, autoimmune disease, inflammatory disease, diabetes, cardiovascular disease, cancer, periodontal disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders

Trademark Events

Jan 19, 2024

Notice Of Approval Of Extension Request E-Mailed

Jan 17, 2024

Sou Extension 1 Granted

Jan 17, 2024

Sou Extension 1 Filed

Jan 17, 2024

Sou Teas Extension Received

Aug 8, 2023

Noa E-Mailed - Sou Required From Applicant

Jun 13, 2023

Official Gazette Publication Confirmation E-Mailed

Jun 13, 2023

Published For Opposition

May 24, 2023

Notification Of Notice Of Publication E-Mailed

May 8, 2023

Approved For Pub - Principal Register

May 5, 2023

Teas/Email Correspondence Entered

May 4, 2023

Correspondence Received In Law Office

May 4, 2023

Teas Response To Office Action Received

Feb 21, 2023

Notification Of Non-Final Action E-Mailed

Feb 21, 2023

Non-Final Action E-Mailed

Feb 21, 2023

Non-Final Action Written

Feb 14, 2023

Assigned To Examiner

Oct 26, 2022

Automatic Update Of Assignment Of Ownership

May 3, 2022

New Application Office Supplied Data Entered

Apr 30, 2022

New Application Entered